Amita Gupta, MD, MHS, an expert in the global treatment, prevention and control of diseases such as acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB), has been named the seventh director of the Division of Infectious Diseases of Johns Hopkins Medicine. She takes over the leadership of one of the institution’s largest divisions – with more than 150 faculty members, clinical fellows and postdoctoral fellows – from David Thomas, MD, MPH, who retired after 15 years as as director.
“I am incredibly humbled and honored to take on this position, especially during a pandemic,” says Gupta, professor of medicine at Johns Hopkins University School of Medicine, with a cross-appointment in international health at Johns Hopkins Bloomberg School of Medicine. Public Health. “Due to COVID-19, our division has been called upon to serve harder than ever and at a time when our discipline has never been more important.”
Most recently, Gupta served as Deputy Director of the Johns Hopkins Center for Clinical Global Health Education and remains Co-Chair of the Johns Hopkins India Institute Faculty.
Gupta’s research and clinical interests include global health; Infectious diseases; emerging infections; COVID-19, tuberculosis, human immunodeficiency virus (HIV) and co-infection care and treatment clinical trials in India and other resource-limited countries; prevention of transmission of infectious diseases from mother to child; and antimicrobial resistance.
Gupta has authored over 220 peer-reviewed research publications and has mentored over 35 young scientists in the United States and India.
Since joining Johns Hopkins Medicine in 2003, Gupta has focused primarily on infectious diseases in India, where she leads several Indo-Johns Hopkins research collaborations funded by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) of the United States. ) and the global health initiative Unitaid, among others. She holds senior positions at RePORT India (of which Johns Hopkins is the US coordinating center) and RePORT International, two multilateral global consortia for TB research.
Gupta is also co-principal investigator of the NIH-funded JHU Baltimore-India Clinical Trials Unit, which seeks to identify new treatments and vaccines for HIV, tuberculosis, and other infections worldwide through of the AIDS Clinical Trials Group and the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (for which Gupta is co-chair of the Tuberculosis Scientific Committee and the Inter-Network Working Group on Tuberculosis Vaccines).
Most recently, she was a Fellow of the Johns Hopkins Precision Medicine Center of Excellence for COVID-19.
Gupta’s team in the Division of Infectious Diseases focuses on international trials of drugs to prevent and treat HIV, tuberculosis and the complications associated with these diseases in adults, pregnant women and children, particularly for those residing in low-income and underserved settings. An example is PHOENix MDR-TB (Pprotect Hhouseholds Onot Eexposure to NOTDiagnosed IndeX MultimateDblanket-Rresistant Jyouberculosis Patients), a clinical trial aimed at preventing the disease in adults and children exposed to strains of tuberculosis bacteria that are resistant to many drugs.
The group also conducts epidemiological studies that assess risk factors and biomarkers associated with infectious disease outcomes; sex differences in COVID-19; the links between HIV, inflammation and nutrition in international contexts; TB during pregnancy; and tuberculosis in India, as part of the Indo-American Medical Partnership Tuberculosis Research Cohort.
In 2019, Gupta was nominated by then-US Secretary of Health and Human Services Alex Azar for a four-year term on the National Institute of Allergy and Infectious Diseases Council, the chief advisory board of the NIH agency.
Gupta earned her BS in Materials Science from the Massachusetts Institute of Technology and her MD from Harvard Medical School. She completed her residency in internal medicine at the University of California, San Francisco, followed by fellowships with the CDC’s Epidemic Intelligence Service and Johns Hopkins University School of Medicine. Gupta also holds a master’s degree in health sciences from the Johns Hopkins Bloomberg School of Public Health.
The Division of Infectious Diseases was founded by Ivan Bennett, MD, in 1958. Since its inception, the division has established a community where innovative approaches are developed in education, research and clinical care. The result has been decades of scientific and clinical advancements, distinguished leaders in the field, and first-rate patient care and service.
Warning: AAAS and EurekAlert! are not responsible for the accuracy of press releases posted on EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.